These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8563699)

  • 21. Nonpeptide angiotensin II receptor antagonists. Studies with EXP9270 and DuP 753.
    Wong PC; Price WA; Chiu AT; Carini DJ; Duncia JV; Johnson AL; Wexler RR; Timmermans PB
    Hypertension; 1990 Jun; 15(6 Pt 2):823-34. PubMed ID: 2351436
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological profile of GR117289 in vitro: a novel, potent and specific non-peptide angiotensin AT1 receptor antagonist.
    Robertson MJ; Barnes JC; Drew GM; Clark KL; Marshall FH; Michel A; Middlemiss D; Ross BC; Scopes D; Dowle MD
    Br J Pharmacol; 1992 Dec; 107(4):1173-80. PubMed ID: 1467838
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo pharmacology of L-158,809, a new highly potent and selective nonpeptide angiotensin II receptor antagonist.
    Siegl PK; Chang RS; Mantlo NB; Chakravarty PK; Ondeyka DL; Greenlee WJ; Patchett AA; Sweet CS; Lotti VJ
    J Pharmacol Exp Ther; 1992 Jul; 262(1):139-44. PubMed ID: 1625193
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacological characterization of SR 47436, a new nonpeptide AT1 subtype angiotensin II receptor antagonist.
    Cazaubon C; Gougat J; Bousquet F; Guiraudou P; Gayraud R; Lacour C; Roccon A; Galindo G; Barthelemy G; Gautret B
    J Pharmacol Exp Ther; 1993 May; 265(2):826-34. PubMed ID: 8496828
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacological Profiles of a Highly Potent and Long-Acting Angiotensin II Receptor Antagonist, Fimasartan, in Rats and Dogs after Oral Administration.
    Paik SH; Chi YH; Lee JH; Han HS; Lee KT
    Biol Pharm Bull; 2017; 40(7):992-1001. PubMed ID: 28674263
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nonpeptide angiotensin II receptor antagonists. IX. Antihypertensive activity in rats of DuP 753, an orally active antihypertensive agent.
    Wong PC; Price WA; Chiu AT; Duncia JV; Carini DJ; Wexler RR; Johnson AL; Timmermans PB
    J Pharmacol Exp Ther; 1990 Feb; 252(2):726-32. PubMed ID: 2179532
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanistic differences of various AT1-receptor blockers in isolated vessels of different origin.
    Morsing P; Adler G; Brandt-Eliasson U; Karp L; Ohlson K; Renberg L; Sjöquist PO; Abrahamsson T
    Hypertension; 1999 Jun; 33(6):1406-13. PubMed ID: 10373224
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative study of TA-606, a novel angiotensin II receptor antagonist, with losartan in terms of species difference and orthostatic hypotension.
    Hashimoto Y; Ohashi R; Minami K; Narita H
    Jpn J Pharmacol; 1999 Sep; 81(1):63-72. PubMed ID: 10580372
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-peptide angiotensin II receptor antagonists. 2. Design, synthesis, and biological activity of N-substituted (phenylamino)phenylacetic acids and acyl sulfonamides.
    Dhanoa DS; Bagley SW; Chang RS; Lotti VJ; Chen TB; Kivlighn SD; Zingaro GJ; Siegl PK; Patchett AA; Greenlee WJ
    J Med Chem; 1993 Dec; 36(26):4239-49. PubMed ID: 8277506
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of SR 47436 (BMS-186295), a non-peptide angiotensin AT1 receptor antagonist in hypertensive rat models.
    Lacour C; Canals F; Galindo G; Cazaubon C; Segondy D; Nisato D
    Eur J Pharmacol; 1994 Nov; 264(3):307-16. PubMed ID: 7698170
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prodrugs to improve the oral bioavailability of a diacidic nonpeptide angiotensin II antagonist.
    Aungst BJ; Blake JA; Rogers NJ; Saitoh H; Hussain MA; Ensinger CL; Pruitt JR
    Pharm Res; 1995 May; 12(5):763-7. PubMed ID: 7479565
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Losartan potassium, a nonpeptide antagonist of angiotensin II, chronically administered p.o. does not readily cross the blood-brain barrier.
    Bui JD; Kimura B; Phillips MI
    Eur J Pharmacol; 1992 Aug; 219(1):147-51. PubMed ID: 1397042
    [TBL] [Abstract][Full Text] [Related]  

  • 33. EXP063, a nonpeptide angiotensin II and beta adrenergic receptor antagonist.
    Wong PC; Duncia JV; Chiu AT; Olson RE; Rominger DH; Tam SW; Timmermans PB
    J Pharmacol Exp Ther; 1993 Nov; 267(2):641-7. PubMed ID: 7902431
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacologic characterization of CI-996, a new angiotensin receptor antagonist.
    Keiser JA; Ryan MJ; Panek RL; Hodges JC; Sircar I
    J Pharmacol Exp Ther; 1995 Mar; 272(3):963-9. PubMed ID: 7891350
    [TBL] [Abstract][Full Text] [Related]  

  • 35. BMS-180560, an insurmountable inhibitor of angiotensin II-stimulated responses: comparison with losartan and EXP3174.
    Dickinson KE; Cohen RB; Skwish S; Delaney CL; Serafino RP; Poss MA; Gu Z; Ryono DE; Moreland S; Powell JR
    Br J Pharmacol; 1994 Sep; 113(1):179-89. PubMed ID: 7812609
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo pharmacology of an angiotensin AT1 receptor antagonist with balanced affinity for AT2 receptors.
    Kivlighn SD; Zingaro GJ; Gabel RA; Broten TP; Chang RS; Ondeyka DL; Mantlo NB; Gibson RE; Greenlee WJ; Siegl PK
    Eur J Pharmacol; 1995 Dec; 294(2-3):439-50. PubMed ID: 8750704
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antihypertensive activity of the novel, nonpeptide angiotensin II receptor antagonists BIBS 39 and BIBS 222 in conscious renal hypertensive rats.
    Zhang J; Van Meel JC; Van Zwieten PA
    Pharmacology; 1993 May; 46(5):241-7. PubMed ID: 8488169
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo pharmacology of L-159,913, a new highly potent and selective nonpeptide angiotensin II receptor antagonist.
    Gabel RA; Kivlighn SD; Zingaro GJ; Schorn TW; Schaffer LW; Ashton WT; Chang LL; Flanagan K; Greenlee WJ; Siegl PK
    Clin Exp Hypertens; 1995 Aug; 17(6):931-53. PubMed ID: 7581262
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of U-97018 on pressor responses to intracerebroventricularly administered angiotensin II in conscious normotensive rats.
    Morita O; Kushida H; Kunihara M
    J Cardiovasc Pharmacol; 1995 Jun; 25(6):880-7. PubMed ID: 7564332
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Renal actions of the selective angiotensin AT2 receptor ligands CGP 42112B and PD 123319 in the sodium-depleted rat.
    Macari D; Bottari S; Whitebread S; De Gasparo M; Levens N
    Eur J Pharmacol; 1993 Nov; 249(1):85-93. PubMed ID: 8282023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.